Economic burden of stroke and the evaluation of new therapies

Public Health

Volumn 112, Issue 2, 1998, Pages 103-112

  Kaste, M ^a   Fogelholm, R ^b   Rissanen, A ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Epidemiology; Ischaemic stroke; Outcome evaluation scales

Indexed keywords

FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT;

DEVELOPING COUNTRY; DISABILITY; HEALTH CARE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INDUSTRIALIZATION; MORTALITY; REVIEW; SCORING SYSTEM; SOCIAL WORK; STROKE; TREATMENT OUTCOME; UNITED STATES;

EID: 0031924906     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(98)00593-9     Document Type: Review

References (78)

1. Aho K. et al. Cerebrovascular disease in the community: results of a WHO Collaborative Study. Bull World Health Organ 1980; 58: 113-130.
2. Cerebrovascular diseases: prevention, treatment, and rehabilitation. Report of a WHO Meeting. World Health Organization Technical Report series. No. 469, 1971.
3. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke 1990; 21: 989-992.
4. Thom TJ. Stroke mortality trends. An international perspective. Ann Epidemiol 1993; 3: 509-518.
5. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-114.
6. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet 1987, II: 1196-1200.
7. Bamford J et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. J Neurol Neurosurg Psychiatr 1988; 51: 1373-1380.
8. Kotila M. Declining incidence and mortality of stroke? Stroke 1984; 15: 255-259.
9. Anderson CS et al. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993; 158: 80-84.
10. Alter M et al. Standardized incidence ratios of stroke: a worldwide review. Neuroepidemiology 1986; 5: 148-158.
11. Kotila M. Decline in the incidence of stroke (Letter). Stroke 1988; 19: 1572-1573.
12. Sarti C et al. Declining trend in incidence, case-fatality and mortality of stroke in three geographic areas of Finland during 1983-1989. Results from the FINMONICA Stroke Register. J Clin Epidemiol 1994; 47: 1259-1269.
13. Terént A. Increasing incidence of stroke among Swedish women. Stroke 1988; 19: 598-603.
14. Jörgensen HS, Plesner A-M, Hübbe P, Larsen K. Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke 1992; 23: 1701-1704.
15. Broderick JP et al. Incidence rates of stroke in the eighties: The end of the decline in stroke? Stroke 1989; 20: 577-582.
16. Harmsen P, Tsipogianni A, Wilhelmsen L. Stroke incidence rates were unchanged, while fatality rates declined, during 1971-1987 in Göteborg, Sweden. Stroke 1992; 23: 1410-1415.
17. Lindenström E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976-1988. Stroke 1992; 23: 28-32.
18. Wolf PA et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992; 23: 1551-1555.
19. Bonita R, Broad JB, Beaglehole R. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet 1993; 342: 1470-1473.
20. Bonita R, Beaglehole R. Explaining stroke mortality trends. Lancet 1993; 341: 1510-1511.
21. Fogelholm R, Nuutila M, Vuorela A-L. Primary intracerebral haemorrhage in the Jyväskylä region, Central Finland, 1985-89, incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatr 1992; 55: 546-552.
22. Fogelholm R, Hernesniemi J, Vapalahti M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 1993; 24: 1649-1654.
23. Bamford J et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatr 1990; 53: 16-22.
24. Rissanen A. Cerebrovascular disease in the Jyväskylä Region, Central Finland. Thesis. University of Kuopio, Kuopio.
25. Thorvaldsen P et al. Stroke incidence, case fatality, and mortality m the WHO MONICA Project. Stroke 1992; 26: 361-367.
26. Stegmayr B, Asplund K, Wester PO. Trends in incidence, case-fatality rate, and severity of stroke in Northern Sweden, 1985-1991. Stroke 1994; 25: 1738-1745.
27. Kòrv J, Roose M, Kaasik A-E. Changed incidence and case-fatality rates of first-ever stroke between 1970 and 1993 in Tartu, Estonia. Stroke 1996, 27: 199-203.
28. Shahar E et al. Improved survival of stroke patients during the 1980s. The Minnesota Stroke Survey. Stroke 1995; 26: 1-6.
29. Davenport RJ, Dennis MS, Warlow CP. Effect of correcting outcome data for case mix: an example from stroke medicine. BMJ 1996; 312: 1503-1505.
30. Christie D. Prevalence of stroke and its sequelae. Med J Aust 1981; II: 182-184.
31. Aho K et al. Prevalence of stroke in Finland. Stroke 1986; 17: 681-686.
32. del Zoppo GJ. Acute stroke - On the threshold of a therapy? New Engl J Med 1995; 333: 1632-1633.
33. Berk A, Paringer L, Mushkin SJ. The economic cost of illness: fiscal 1975. Med Care 1978; 16: 785-790.
34. Mills E, Thompson M. The economic costs of stroke in Massachusetts. New Engl J Med 1978; 299: 415-418.
35. Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: a comparative analysis. Am J Public Health 1980; 70: 1249-1259.
36. Adelman SM. National survey of stroke: economic impact. Stroke 1981; 12 (Suppl). 69-87.
37. Dombovy M, Sandok B, Basford J. Rehab for stroke: a review. Stroke 1986; 17: 363-365.
38. Vanclay F. Stroke rehabilitation. J Clin Epidemiol 1991; 44: 22-28.
39. Drummond MF, Ward GH. The financial burden of stroke and the economic evaluation of treatment alternatives. In: Stroke: Epidemiological, Therapeutic and Socioeconomic Aspects. Rose FC (ed). Royal Society of Medicine Services Ltd.: London, 1986.
40. Weill C, Schneider T. The cost of cerebrovascular accidents in France in 1982. In: Stroke: Epidemiological, Therapeutic and Socioeconomic Aspects, Rose FC (ed). Royal Society of Medicine Services Ltd.: London, 1986.
41. Terént A et al. Costs of stroke in Sweden A national perspective. Stroke 1994; 25: 2363-2369.
42. Terént A. Medico-social consequences and direct costs of stroke in a Swedish community. Scand J Rehabil Med 1983; 15: 165-171.
43. Waterhouse J, Correa P, Muir C, Powell J (eds). Cancer Incidence in Five Continents, volume 3. I ARC Scientific Publication No. 15: Lyon, 1976.
44. Drummond MF. Principles of Economic Appraisal in Health Care. Oxford University Press: Oxford, 1980.
45. Statistical Year Book of Finland. Central Statistical Office. Valtion Painatuskeskus, Helsinki. 1992.
46. Aboderin I, Venables G. For the Pan European Consensus meeting on Stroke Management. Stroke Management in Europe. J Int Med, 1996; 240: 173-180
47. Diener HC et al. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke 1996; 27: 76-81.
48. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995; 333: 1581-1587.
49. Kaste M, Palomäki H, Sarna S. Where and how should elderly stroke patients be treated? Stroke 1995; 26: 249-253.
50. Brott T et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
51. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-65.
52. Rankin J. Cerebral vascular accidents in patients over the age of 60: II prognosis. Scottish Med J 1957; 2: 200-215.
53. Bamford JM, Sandercock PAG, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; 20: 828.
54. Teasdale G, Knill-Jones R, van der Sande J. Observer variability in assessing impaired consciousness and coma. J Neurol Neurosurg Psychiatr 1978; 41: 603-610.
55. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke - background and study protocol. Stroke 1985; 16: 885-890
56. Hacke W et al for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke (ECASS). JAMA 1995; 274: 1017-1025.
57. A Special Writing Group of the Stroke Council, American Heart Association (Adams HP et al). Use of thrombolytic drugs. A supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1994; 25: 1901-1914.
58. Sherman DG et al. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1989; 41: 708-710.
59. Barnett HJM, Bennett MS, Mohr JP, Yatsu FM (eds). Stroke: Pathophysiology, Diagnosis, and Management. Churchill Livingstone, USA, 1992.
60. Kaste M, Hacke W, Fieschi C. von Kummer R, for the ECASS Study Group. Baseline CT and effects of the time to treatment on, hemorrhages, mortality and clinical outcome in ECASS. Post hoc analysis, pp. 249-258, In Robertson JT, Nowak TS (eds) Frontiers in cerebro vascular disease: mechanisms, diagnosis and treatment. Futura Publishing Company, Inc. Armonk, NY, USA, 1998.
61. Kaste M et al A randomized, double-blind, placebo-controlled trial on nimodipinc in acute ischemic hemispheric stroke. Stroke 1994; 25: 1348-1353.
62. Lindley R (International Stroke Trial Collaborative Group). Very simple methods of assessing of outcome after stroke can be valid. Cerebrovasc Dis 1992; 2: 209.
63. van Gijn J, Warlow CP. Down with stroke scales! Cerebrovasc: Dis 1992; 2: 244-246
64. Hommel M et al for the MAST Study Group. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet 1994; 345: 57.
65. Donnan GA et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1994; 345: 578-579.
66. The RANTTAS investigators. Randomized trial of tirilazad in acute stroke (RANTTAS). Stroke 1996; 27: 195.
67. de Haan R et al. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993; 24: 1178-1181.
68. Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46: 660-662.
69. Côté R et al. The Canadian Neurological Scale: Validation and reliability assessment. Neurology 1989; 39: 638-643.
70. Lindenström E et al. Reliability of Scandinavian neurological stroke scale. Cerebrovasc Dix 1991; 1: 103-107.
71. Orgogozo JM, Dartigues JF. Methodology of clinical trials in acute cerebral ischemia. Cerebrovasc Dis 1991; 1 (Suppl 1): 100-111.
72. Task Force on Stroke Impairment, Task Force on Stroke Disability, and Task Force on Stroke Handicap. Symposium recommendations for methodology in stroke outcome research. Stroke 1990; 21 (Suppl II): II-68-II-73.
73. van Gijn J. Measurement of outcome in stroke prevention trials. Cerebrovasc Dis 1992. 2 (Suppl 1): 23-34.
74. Hantson L, DeKeyser J. Neurological scales in the assessment of cerebral infarction Cerebrovasc Dis 1994; 4 (Suppl 2): 7-14.
75. van Swieten JC et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
76. de Haan R et al. Measuring quality of life in stroke. Stroke 1993; 24: 320-327.
77. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing 1983; 12: 166-170.
78. Bergner M, Bobbit RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19 (8): 787-805.